The transcriptomic overlap of enhanced inflammatory genes caused by either iASPP deletion or p53 mutation supports the idea that elevated inflammation is a common mechanism for bypassing p53 tumour suppression. The gene discussed is PPP1R13L; the disease is neoplasm.